en.wikipedia.org/wiki/Novartis

Novartis International AG is a Swiss multinational pharmaceutical company based in Basel, .... Vaccines and Diagnostics Division: In 2013,Novartis announced it was considering selling this division off. While "sales in the unit were up 14% for ...

en.wikipedia.org/wiki/Chiron_Corporation

Chiron Corporation was an American multinational biotechnology firm based in Emeryville, ... Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while ... for cancer drugs; the Biocine Company, for vaccines; Chiron Diagnostics, for blood screening and other diagnostic tests ...

www.novartis.com

Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.

scrip.pharmaintelligence.informa.com/companies/198601375

This latest roundup includes EFPIA's appointment of Nathalie Moll to director general, CEO appointments by YposKesi and Symbiomix Therapeutics, as well as ...

www.pharmamedtechbi.com/companies/198601375

Novartis Vaccines & Diagnostics Inc. / www.novartis-vaccines.com. A Division of Novartis AG / Company # 198601375. + Show All | – Hide All ...

www.linkedin.com/company/novartis-vaccines-and-diagnostics-inc.

Learn about working at Novartis Vaccines and Diagnostics, Inc.. Join LinkedIn today for free. See who you know at Novartis Vaccines and Diagnostics, Inc., ...

www.biospace.com/employer/539719/novartis-vaccines

Novartis Vaccines & Diagnostics, Inc. Begins Shipment of Seasonal Influenza Vaccine Fluvirin(R) to U.S. Market to Help Protect Ahead of 2010-2011 Flu Season.

law.justia.com/cases/federal/district-courts/new-york/nysdce/1:2018cv02434/490410/86

Oct 24, 2018 ... Novartis Vaccines and Diagnostics, Inc. et al v. Regeneron Pharmaceuticals, Inc., No. 1:2018cv02434 - Document 86 (S.D.N.Y. 2018) case ...

law.justia.com/cases/federal/district-courts/new-york/nysdce/1:2018cv02434/490410/174

Mar 20, 2019 ... Novartis Vaccines and Diagnostics, Inc. et al v. Regeneron Pharmaceuticals, Inc., No. 1:2018cv02434 - Document 174 (S.D.N.Y. 2019) case ...